SciClone Pharmaceuticals Inc (NASDAQ:SCLN)

7.95
Delayed Data
As of Mar 04
 +0.07 / +0.89%
Today’s Change
4.24
Today|||52-Week Range
9.14
-9.25%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 4
2013
Quarter 1
2014
Quarter 2
2014
Quarter 3
2014
Revenue and IncomeNet Revenues32.7M26.6M32.5M34.3M
 
 
 
 
 
Cost of Goods Sold6.0M4.6M5.0M6.0M
 
 
 
 
 
Depreciation And Amortization215.0K207.0K224.0K221.0K
 
 
 
 
 
 
Operating ExpensesGross Income26.5M21.8M27.3M28.1M
 
 
 
 
 
General Expenses22.5M17.1M17.6M20.0M
 
 
 
 
 
Research And Development927.0K1.3M580.0K432.0K
 
 
 
 
 
Total Operating Expenses28.7M21.9M22.9M26.2M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income4.0M4.7M9.6M8.1M
 
 
 
 
 
Extraordinary Credit3.2M----0.00
 
 
Extraordinary Charge-1.2M----0.00
 
 
Interest Expense On Debt8.0K29.0K19.0K0.00
 
 
 
 
Other Expenses-5.2M-119.0K30.0K108.0K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income850.0K4.5M9.7M8.2M
 
 
 
 
 
Income Taxes-814.0K-398.0K-34.0K-331.0K
 
 
 
 
 
Net Income36.0K4.1M9.6M7.9M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS52.6M52.0M51.6M51.0M
 
 
 
 
 
Shares To Calculate EPS Diluted53.8M53.2M52.8M52.4M
 
 
 
 
 
 
Earnings Per ShareEPS$0.00$0.08$0.18$0.15
 
 
 
 
EPS Diluted$0.00$0.08$0.18$0.15
 
 
 
 
 
 

To view my watchlist

Not a member yet?

Sign up now for a free account